Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study

[1] Li Q(2020)Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med 382 1199-1207

[2] Guan X(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan China Lancet 395 497-506

[3] Wu P(2021)Immune determinants of COVID-19 disease presentation and severity Nat Med 27 28-33

[4] Wang X(2020)for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in patients after acute COVID-19 JAMA 324 603-5

[5] Zhou L(2020)Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 J Infect 81 E4-E6

[6] Tong Y(2020)Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients Natl Sci Rev 7 998-1002

[7] Huang C(2021)Post-acute COVID-19 syndrome Nat Med 27 601-615

[8] Wang Y(2020)Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Nat Med 26 1200-1204

[9] Li X(2020)Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild COVID-19 N Engl J Med 383 1085-1087

[10] Ren L(2021)Persistence of IgG response to SARS-CoV-2 Lancet Infect Dis 21 163-164

[1] Li Q(2020)Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia N Engl J Med 382 1199-1207

[2] Guan X(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan China Lancet 395 497-506

[3] Wu P(2021)Immune determinants of COVID-19 disease presentation and severity Nat Med 27 28-33

[4] Wang X(2020)for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in patients after acute COVID-19 JAMA 324 603-5

[5] Zhou L(2020)Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 J Infect 81 E4-E6

[6] Tong Y(2020)Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients Natl Sci Rev 7 998-1002

[7] Huang C(2021)Post-acute COVID-19 syndrome Nat Med 27 601-615

[8] Wang Y(2020)Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections Nat Med 26 1200-1204

[9] Li X(2020)Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild COVID-19 N Engl J Med 383 1085-1087

[10] Ren L(2021)Persistence of IgG response to SARS-CoV-2 Lancet Infect Dis 21 163-164